Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Stomatitis 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Low-Level Light Therapy 6Cisplatin 5avasopasem manganese 4Radiotherapy, Intensity-Modulated 4Standard of Care 3Injections 3Fibroblast Growth Factor 7 3golotimod 2Water 2Vitamin B 12 2Sodium Bicarbonate 2Saline Solution 2Radiotherapy 2RRx-001 2Propolis 2Mouthwashes 2Honey 2Gentamicins 2whole grape extract 1sargramostim 1samital 1regramostim 1oxycodone-acetaminophen 1dusquetide 1clazakizumab 1brilacidin 1alfacalcidol 1Xylitol 1Valacyclovir 1Traumeel S 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomatitis × brilacidin × Head & Neck × Clear all
NCT02324335 2019-01-16

Brilacidin

Innovation Pharmaceuticals, Inc.

Phase 2 Completed
61 enrolled 12 charts
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡